BioMarin Pharmaceutical Insider Trades
NASDAQ: BMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 5 · $4.32M
- Shares bought / sold
- 0 / 69.71K
- Net activity
- Net selling $4.3 million
BioMarin Pharmaceutical insider activity
Over the last 12 months, BioMarin Pharmaceutical insiders reported 45 transactions on SEC Form 4: 0 open-market purchases and 5 sales. Insiders bought $0 and sold $4.3 million worth of stock, for net insider selling of $4.3 million. The largest seller was Davis George Eric, with $2.8 million in reported sales.
The most recent filing shows Friberg Gregory R (EVP, Chief R&D Officer) reporting a transaction in 4,086 shares at $60.00 on Sep 30, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BMRN's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
BMRN insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 30, 2026 | Friberg Gregory REVP, Chief R&D Officer | Tax withholding | 4,086 | $245.16K | Form 4 |
| Sep 10, 2026 | Plenge Robert MDirector | Award | 6,140 | — | Form 4 |
| Sep 2, 2026 | Davis George EricEVP, Chief Legal Officer | Sale | 17,557 | $1.16M | Form 4 |
| Jun 2, 2026 | ANDERSON ELIZABETH MDirector | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Bodem Barbara W.Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | CLARK IAN TDirector | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Dere Willard HDirector | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Enyedy Mark JDirector | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | HOMBACH ROBERT J.Director | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Ho MaykinDirector | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Walbert Timothy PDirector | Award | 7,490 | — | Form 4 |
| Jun 2, 2026 | Countouriotis AthenaDirector | Award | 7,490 | — | Form 4 |
| May 20, 2026 | Hubbard CristinEVP, Chief Commercial Officer | Tax withholding | 2,318 | $116.36K | Form 4 |
| May 7, 2026 | Friberg Gregory REVP, Chief R&D Officer | Sale | 3,281 | $176.68K | Form 4 |
| Mar 18, 2026 | Davis George EricEVP, Chief Legal Officer | Tax withholding | 1,273 | $71.35K | Form 4 |
| Mar 17, 2026 | Hubbard CristinEVP, Chief Commercial Officer | Tax withholding | 1,245 | $69.78K | Form 4 |
| Mar 17, 2026 | Friberg Gregory REVP, Chief R&D Officer | Tax withholding | 1,629 | $91.31K | Form 4 |
| Mar 17, 2026 | Hardy AlexanderChief Executive Officer | Tax withholding | 4,252 | $238.32K | Form 4 |
| Mar 17, 2026 | Mueller BrianEVP, Chief Financial Officer | Tax withholding | 2,117 | $118.66K | Form 4 |
| Mar 17, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Tax withholding | 1,693 | $94.89K | Form 4 |
| Mar 16, 2026 | Hardy AlexanderChief Executive Officer | Award | 62,440 | — | Form 4 |
| Mar 16, 2026 | Mueller BrianEVP, Chief Financial Officer | Award | 18,740 | — | Form 4 |
| Mar 16, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Award | 14,990 | — | Form 4 |
| Mar 16, 2026 | Davis George EricEVP, Chief Legal Officer | Award | 14,570 | — | Form 4 |
| Mar 16, 2026 | Davis George EricEVP, Chief Legal Officer | Tax withholding | 7,177 | $419.93K | Form 4 |
| Mar 16, 2026 | Hubbard CristinEVP, Chief Commercial Officer | Award | 15,410 | — | Form 4 |
| Mar 16, 2026 | Friberg Gregory REVP, Chief R&D Officer | Award | 19,150 | — | Form 4 |
| Mar 13, 2026 | Hardy AlexanderChief Executive Officer | Tax withholding | 2,941 | $172.08K | Form 4 |
| Mar 13, 2026 | Mueller BrianEVP, Chief Financial Officer | Tax withholding | 9,945 | $581.88K | Form 4 |
| Mar 13, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Tax withholding | 9,109 | $532.97K | Form 4 |
| Mar 11, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Sale | 16,486 | $996.74K | Form 4 |
| Feb 26, 2026 | Davis George EricEVP, Chief Legal Officer | Sale | 26,061 | $1.60M | Form 4 |
| Feb 26, 2026 | Friberg Gregory REVP, Chief R&D Officer | Sale | 6,326 | $381.94K | Form 4 |
| Feb 25, 2026 | Mueller BrianEVP, Chief Financial Officer | Award | 2,569 | — | Form 4 |
| Feb 25, 2026 | Mueller BrianEVP, Chief Financial Officer | Award | 7,230 | — | Form 4 |
| Feb 25, 2026 | Mueller BrianEVP, Chief Financial Officer | Award | 6,683 | — | Form 4 |
| Feb 25, 2026 | Davis George EricEVP, Chief Legal Officer | Award | 2,372 | — | Form 4 |
| Feb 25, 2026 | Davis George EricEVP, Chief Legal Officer | Award | 6,675 | — | Form 4 |
| Feb 25, 2026 | Davis George EricEVP, Chief Legal Officer | Award | 6,177 | — | Form 4 |
| Feb 25, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Award | 2,371 | — | Form 4 |
| Feb 25, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Award | 6,675 | — | Form 4 |
| Feb 25, 2026 | Guyer Charles GregEVP, Chief Technical Officer | Award | 6,176 | — | Form 4 |
| Jan 20, 2026 | Ramchandani Rashmi VirendraVP, Chief Accounting Officer | Award | 7,070 | — | Form 4 |
| Jan 20, 2026 | Ramchandani Rashmi VirendraVP, Chief Accounting Officer | Award | 18,540 | — | Form 4 |
| Dec 1, 2025 | Hardy AlexanderChief Executive Officer | Tax withholding | 16,570 | $911.85K | Form 4 |
| Sep 30, 2025 | Friberg Gregory REVP, Chief R&D Officer | Tax withholding | 3,304 | $178.94K | Form 4 |
| Aug 1, 2025 | CLARK IAN TDirector | Award | 7,000 | — | Form 4 |
| May 20, 2025 | Dere Willard HDirector | Award | 6,650 | — | Form 4 |
| May 20, 2025 | Enyedy Mark JDirector | Award | 6,650 | — | Form 4 |
| May 20, 2025 | Ho MaykinDirector | Award | 6,650 | — | Form 4 |
| May 20, 2025 | HOMBACH ROBERT J.Director | Award | 6,650 | — | Form 4 |
| May 20, 2025 | Hubbard CristinEVP, Chief Commercial Officer | Tax withholding | 2,155 | $129.15K | Form 4 |
| May 20, 2025 | MEIER RICHARD ADirector | Award | 6,650 | — | Form 4 |
| May 20, 2025 | Walbert Timothy PDirector | Award | 6,650 | — | Form 4 |
| Apr 30, 2025 | Hardy AlexanderChief Executive Officer | Award | 375 | $20.30K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4